A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...

NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced an update to the prescribing information for ELEVIDYS (delandistrogene moxeparvovec-rokl), the ...

Researchers successfully developed a machine learning-based method for predicting symptom deterioration in patients with cancer.

In TUXEDO-2, ticagrelor failed to meet the bar for noninferiority, with most outcomes hinting at an advantage for prasugrel.

Adults hospitalized for acute COPD exacerbation faced elevated odds for all-cause mortality and ICU admission if they had end-stage renal disease and were on dialysis, according to data presented at ...

Doctors warn that not every winter cough is caused by pollution—some may signal early pneumonia. Understanding your symptoms ...

The device may help boost early detection of HFrEF for people living in low-resource settings where echo is scarce.

Allergan Aesthetics, an AbbVie company , today announced it will present data highlighting efficacy, safety and patient-reported outcomes across its portfolio during the 2025 American Society of ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to ...

Disclaimer: This article is for educational purposes only and does not replace medical advice. If you are experiencing ...